Efficacy, safety and dose selection of AZD3759 in patients with untreated EGFR-mutated non-small-cell lung cancer and central nervous system metastases in China (CTONG1702-Arm 8): a multi-center, single-arm, phase 2 trial.
Maggie Liu SY, Dong XR, Wang Z, Du Y, Cui JW, Chu Q, Xu BF, Zheng MY, Deng JY, Lu C, Wei XW, Li YS, Zheng MM, Yang MY, Huang J, Li A, Bai XY, Sun YL, Xu CR, Wang BC, Chen HJ, Yang JJ, Yan HH, Zhong WZ, Zhou Q, Wu YL.
Maggie Liu SY, et al. Among authors: bai xy.
EClinicalMedicine. 2023 Sep 22;64:102238. doi: 10.1016/j.eclinm.2023.102238. eCollection 2023 Oct.
EClinicalMedicine. 2023.
PMID: 37781161
Free PMC article.